Ibrahimovi
TL2 Member · Dresden, DE
UK-based. Mostly the access and pricing categories.
Joined 11 June 2025 · last posted 8d · groups: regional-uk, regional-apac
78 posts, newest first. Showing up to 150.
-
GIP receptor agonism and the argument about direction — does this still hold? Replied, post #12 · Pharmacology › Receptor biology · 20 Jul 2026 · 27 likes Building on post #9 rather than restating it. Biased agonism — where different ligands at the same receptor favour different downstream pathways — is a plausible…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #27 · Start Here › Welcome · 10 Jul 2026 · 0 likes Reading order: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Request: a per-category review queue Replied, post #80 · Meta › Feature requests · 5 Jul 2026 · 3 likes Request that would help newcomers more than regulars: show the subcategory description on hover in the category list. The names are terse and the descriptions are good.
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #71 · Meta › Announcements · 25 Jun 2026 · 7 likes Practical experience of Trust level 3 requirements, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #4 · Access › International · 7 Jun 2026 · 8 likes Building on the opening post rather than restating it. Both are useful and they are different contributions. A first-hand account and a citation answer different halves…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #63 · Access › Insurance & coverage · 7 Jun 2026 · 0 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Official shortage notices and what they authorise Replied, post #91 · Access › Shortages · 6 Jun 2026 · 15 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #97 · Sourcing › Red flags · 6 Jun 2026 · 16 likes Reporting rather than recommending, on certificate whose chromatogram axes. What happened is above. Whether it should have is a different question and not one I am…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #33 · Analytics › Impurities & related substances · 31 May 2026 · 6 likes Reframing Endotoxin slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how…
-
Official shortage notices and what they authorise Replied, post #74 · Access › Shortages · 28 May 2026 · 27 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #39 · Practice › Dosing & titration · 21 May 2026 · 3 likes Everything in post #35 holds. The case it does not cover is the one I have. Micro-titration sits at the boundary between what this community can usefully discuss and…
-
What a certificate commits its issuer to — one year on Replied, post #71 · Analytics › COA interpretation · 19 May 2026 · 3 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #13 · Clinical › Special populations · 17 May 2026 · 12 likes I keep a log for bariatric surgery history specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing…
-
How this community labels and discusses unrefereed work — the long version Replied, post #5 · Evidence › Preprints · 10 May 2026 · 0 likes Confirming post #2 from a second method, which matters more than confirming it from a second person. Unrefereed work is not worthless and a great deal of it survives…
-
GLP-1 receptor distribution: central and peripheral Replied, post #43 · Pharmacology › Receptor biology · 4 May 2026 · 3 likes Narrowing post #40, because the general version has more than one answer. Biased agonism — where different ligands at the same receptor favour different downstream…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #77 · Devices › Syringes & needles · 1 May 2026 · 0 likes Post #73 describes the usual case. This is about the unusual one. The thing about 0.3 ml versus 0.5 ml that took me longest to accept is that a plausible mechanism is…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #94 · Compounds › Tirzepatide · 23 Apr 2026 · 10 likes Post #92 put the caveat in the right place and I want to underline it. The practical version of 2.5 mg starting dose is three sentences long. The rigorous version is…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #16 · Analytics › HPLC & UHPLC · 22 Apr 2026 · 15 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
A parcel stationary at a customs facility for nine days Replied, post #50 · Sourcing › Logistics · 19 Apr 2026 · 7 likes Worth separating two things that post #48 runs together. Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling…
-
Amylin receptor signalling and satiety — what changed since Replied, post #60 · Pharmacology › Receptor biology · 11 Apr 2026 · 0 likes Receptor distribution explains the side-effect profile better than anything else. GLP-1 receptors in the gastrointestinal tract and the area postrema account for most…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #29 · Sourcing › Red flags · 11 Apr 2026 · 27 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
-
CJC-1295 with and without DAC: what the modification does Replied, post #22 · Compounds › Secretagogues & GH axis · 29 Mar 2026 · 2 likes Post #18 describes the usual case. This is about the unusual one. Counterpoint on CJC-1295, offered without confidence: the same observation is consistent with a much…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #38 · Practice › Storage & stability · 24 Mar 2026 · 14 likes Picking up post #36: that is the part I would want checked first. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
-
Revisiting: Absolute versus relative contraindications Replied, post #50 · Safety › Contraindications · 23 Mar 2026 · 7 likes That reframing is the whole thing. The facts I already had.
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #74 · Compounds › Cagrilintide & amylin analogues · 18 Mar 2026 · 15 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Oral versus injected administration claims for BPC-157 Replied, post #18 · Compounds › Repair & healing peptides · 15 Mar 2026 · 29 likes Coming back to post #14, because the follow-up matters more than the original answer. Route arguments — local versus systemic — are made confidently in this subcategory…
-
Micro-titration: a disputed topic, argued properly Replied, post #45 · Practice › Dosing & titration · 12 Mar 2026 · 16 likes Coming back to post #44, because the follow-up matters more than the original answer. The version of micro-titration that circulates here is a simplification of a…
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #24 · Practice › Dosing & titration · 11 Mar 2026 · 1 like This follows post #22 rather than contradicting it. I have no financial interest in anything named in this thread and I want to say so before I comment on splitting a…
-
How to tell whether your question is already answered on a maintained page Replied, post #8 · Start Here › Welcome · 11 Mar 2026 · 0 likes Useful. I have added it to my own notes with the date on it.
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #23 · Outcomes › Body composition · 9 Mar 2026 · 4 likes A note on how Ultrasound and skinfolds gets discussed rather than on Ultrasound and skinfolds itself: the confident posts get the replies and the careful ones get…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #63 · Clinical › Bloodwork · 29 Jan 2026 · 6 likes General information rather than advice about anyone's care. A single value outside a reference interval, on a single draw, in an otherwise unremarkable panel, is…
-
Follow-up: Search filters: what is missing Replied, post #23 · Meta › Site feedback · 29 Jan 2026 · 1 like Appreciated. The plain phrasing does more work here than a longer post would.
-
Filter needles: when they help and what they cost you Replied, post #35 · Devices › Syringes & needles · 25 Jan 2026 · 0 likes Post #33 describes the usual case. This is about the unusual one. U-100 means the barrel is graduated for a solution containing one hundred units of insulin per…
-
Liver enzymes drifting down and what that usually means Replied, post #49 · Clinical › Bloodwork · 23 Jan 2026 · 0 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. That holds under the stated conditions and I have…
-
A partial dose because the pen emptied mid-injection Replied, post #4 · Practice › Administration · 6 Jan 2026 · 17 likes Two things can be true about partial dose because the pen at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument…
-
The decimal-point error, and the habit that catches it Replied, post #27 · Practice › Reconstitution · 14 Dec 2025 · 0 likes I read post #25 twice before replying, because I had assumed the opposite. The arithmetic on decimal-point error is the easy part and it is where the errors are, which…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #67 · Compounds › Tirzepatide · 22 Oct 2025 · 27 likes Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak. Different populations, different durations, different…
-
Titles that describe the question, not the situation Replied, post #115 · Start Here › How to Ask · 7 Oct 2025 · 1 like A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
A preprint whose numbers changed substantially at publication Replied, post #80 · Evidence › Preprints · 6 Oct 2025 · 16 likes Post #76 and I disagree about the size of the effect, not about the direction. Do not build anything on a preprint that you would mind rebuilding: if the preprint later…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #136 · Access › Insurance & coverage · 26 Sep 2025 · 13 likes Worth separating two things that post #132 runs together. The version of Reading a denial letter that I was taught turned out to be a teaching simplification. Useful,…
-
[2026 update] A certificate with no method stated: what can you conclude? Started this topic · Analytics › COA interpretation · 4 Sep 2025 · 12 likes A certificate with no method stated: what can you conclude? — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #31 · Analytics › Mass spectrometry · 26 Aug 2025 · 31 likes Narrowing post #30, because the general version has more than one answer. Resolution and mass accuracy are different specifications. An instrument can resolve two…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #47 · Compounds › Semaglutide · 24 Aug 2025 · 11 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Hypertension improvement and when medication needs revisiting Replied, post #21 · Clinical › Comorbidities · 23 Aug 2025 · 0 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
When a preprint is the best available evidence and we say so Replied, post #71 · Evidence › Preprints · 18 Aug 2025 · 5 likes Saving this. It is the version I will quote when the question comes round again.
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #22 · Evidence › Preprints · 17 Aug 2025 · 23 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Pages past their review date, listed Replied, post #17 · Meta › Wiki maintenance · 13 Aug 2025 · 7 likes Review dates: each maintained page has a review date (the date by which it should be checked). If a page is past its review date, flagging it here alerts the maintainer.
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #30 · Start Here › How to Ask · 27 Jul 2025 · 7 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
Revisiting: Why I ask for the gradient before I discuss the number Replied, post #12 · Analytics › HPLC & UHPLC · 17 Jul 2025 · 2 likes Fair, and the limits you put on it are the part I will remember.
-
Sequence verification for an obscure compound: how it is done Replied, post #92 · Compounds › Other compounds · 14 Jul 2025 · 7 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #122 · Compounds › Tirzepatide · 28 Jun 2025 · 20 likes On post #118 — agreed on the reasoning, with one qualification. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction —…
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #30 · Evidence › Trials · 13 Jun 2025 · 0 likes Nothing in a trial report is medical advice about an individual, and the gap between a population estimate and a person is exactly where clinical judgement lives. That…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #106 · Clinical › Comorbidities · 6 Jun 2025 · 22 likes Narrowing post #103, because the general version has more than one answer. Renal function affects clearance for some compounds in this class and not others. The…
-
Reading a chromatogram someone posted without axes Replied, post #40 · Analytics › HPLC & UHPLC · 2 Jun 2025 · 9 likes Where the baseline is drawn is the least documented and most consequential choice in the whole determination. Valley-to-valley, tangent skim and forced-to-zero can span…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #123 · Compounds › Semaglutide · 18 May 2025 · 19 likes Coming back to post #121, because the follow-up matters more than the original answer. SELECT is a question about a distribution, not about a value, and treating it as…
-
Antibiotics and a course of something with delayed emptying Replied, post #15 · Practice › Interactions · 5 Apr 2025 · 0 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #35 · Sourcing › Vendor reports · 29 Mar 2025 · 3 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.
-
Reading an MS report that only gives you a single number Replied, post #33 · Analytics › Mass spectrometry · 20 Mar 2025 · 0 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
-
Maintainer handover: how it works Replied, post #65 · Meta › Wiki maintenance · 18 Mar 2025 · 0 likes The bit of maintainer handover that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread…
-
Consistent declarations and why they matter more than clever ones Replied, post #120 · Sourcing › Logistics · 3 Mar 2025 · 29 likes Post #119 answers the question as asked. The question underneath it is different. Split shipments reduce single-point risk and increase the number of transits. Which…
-
Distinguishing a deletion sequence by mass alone Replied, post #22 · Analytics › Mass spectrometry · 27 Jan 2025 · 0 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #5 · Sourcing › Vendor reports · 15 Jan 2025 · 16 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere.
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #27 · Practice › Dosing & titration · 15 Jan 2025 · 24 likes Marking my uncertainty on Holding a dose explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
Recovery when intake is low: what to cut first Replied, post #60 · Nutrition & Training › Resistance training · 13 Jan 2025 · 0 likes Coming back to post #56, because the follow-up matters more than the original answer. Whatever the answer on recovery turns out to be, the method for getting there is…
-
A promotion I argued against, and why I lost Replied, post #59 · Documentation › Doc review · 12 Jan 2025 · 1 like Two claims get bundled together under promotion and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one —…
-
Preparing for an appointment: one page, three questions Replied, post #4 · Clinical › Prescriber conversations · 9 Jan 2025 · 19 likes A pharmacist can answer a great many of the questions people save for a prescriber, faster and often better, particularly about interactions and formulations. That is…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #44 · Data & Tools › Calculators · 7 Jan 2025 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Coming back to: Renal impairment: what the labelling says about dose Replied, post #27 · Clinical › Special populations · 6 Jan 2025 · 0 likes I would put moderate confidence on the mainstream reading of Renal impairment and no more. That is not scepticism for its own sake; it is where the sourcing actually…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #78 · Compounds › Semaglutide · 6 Jan 2025 · 3 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
-
Books and papers worth reading that are not about this at all Replied, post #7 · Lounge › Off topic · 1 Jan 2025 · 9 likes What I want from this books and papers thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #7 · Regional › UK & Ireland · 28 Dec 2024 · 0 likes Clinical guidance published for prescribers is public and answers most eligibility questions here more precisely than the discussion does. Take the reasoning and check…
-
Second pass at: Regression to the mean in progress reports Replied, post #3 · Research Methods › Statistics · 17 Dec 2024 · 14 likes On Regression I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #9 · Practice › Side effects · 17 Nov 2024 · 5 likes Post #5 put the caveat in the right place and I want to underline it. Injection-site reactions is a good example of a question where the honest answer is boring and the…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #75 · Compounds › Repair & healing peptides · 17 Nov 2024 · 24 likes Understood. Thank you for being specific about the limits of it.
-
Progressive overload when the scale is falling — one year on Replied, post #84 · Nutrition & Training › Resistance training · 23 Sep 2024 · 12 likes A definition problem is doing most of the work in this Progressive overload discussion. Once the term is pinned down I suspect the disagreement mostly goes away and…
-
Coming back to: Prediction intervals and why they are more honest than confidence… Replied, post #2 · Evidence › Meta-analyses · 7 Sep 2024 · 0 likes A note on scope: what I am saying about Prediction intervals applies to the case in the first post and I would not extend it further without checking.
-
Revisiting: US compounding rules and how they changed Replied, post #5 · Regional › North America · 21 Aug 2024 · 0 likes This follows post #2 rather than contradicting it. Shortage status determines what compounding is permitted in some jurisdictions, which is why the availability…
-
Identical chromatograms across two different lots Replied, post #14 · Sourcing › Red flags · 12 Aug 2024 · 9 likes Keep the two claims separate. "The result on this lot did not match the certificate" is a report that can be checked. "This supplier is dishonest" is an allegation…